RecruitingNCT02686125

Vercise™ DBS Dystonia Prospective Study

Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia

Sponsor

Boston Scientific Corporation

Enrollment

300 participants

Start Date

Mar 7, 2016

Study Type

OBSERVATIONAL

Conditions

Dystonia

Summary

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

Eligibility

Min Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Deep Brain Stimulation (DBS) for people with dystonia. The study is currently recruiting participants at 36 locations. People eligible for this study include aged 7 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDeep Brain Stimulation (DBS)

Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their dystonia symptoms will be offered participation in this registry.

Locations(36)

AZ Sint-Lucas

Ghent, Belgium

UZ Gasthuisberg

Leuven, Belgium

Queen Elizabeth II Health Sciences Center

Halifax, Canada

University Berlin, Charite Virchow Standort, Wedding

Berlin, Germany

Uniklinik Köln

Cologne, Germany

Universitaetsklinikum Dusseldorf

Düsseldorf, Germany

Universitaetsklinikum Freiburg

Freiburg im Breisgau, Germany

Universitaetsklinik Eppendorf

Hamburg, Germany

St. Barbara-Klinik Hamm-Heessen

Hamm, Germany

Medizinische Hochschule Hannover MHH

Hanover, Germany

Universitatsklinikum Campus Kiel

Kiel, Germany

Johannes Gutenberg Universitaet Mainz

Mainz, Germany

Universitaetsklinikum Giessen und Marburg GmbH

Marburg, Germany

Evangelisches Krankenhaus Oldenburg

Oldenburg, Germany

Universitaetsklinikum Wuerzburg

Würzburg, Germany

Medical School of University PECS

Pécs, Hungary

Hadassah Hebrew University Medical Center

Jerusalem, Israel

Azienda Ospedaliero-Universitaria di Ferrara

Ferrara, Italy

Ospedale Dell Angelo

Mestre, Italy

Policlinico Universitario Agostino Gemelli

Rome, Italy

Osp. S. Maria Della Misericordia

Udine, Italy

Haga Ziekenhuis locatie Leyweg

The Hague, Netherlands

10 Military Clinical Hospital Bydgoszcz

Bydgoszcz, Poland

Wojewodzki Szpital Dzieciecy Jozefa Brudzinskiego (Childrens Hospital Bydgoszcz)

Bydgoszcz, Poland

Podmiot Leczniczy Copernicus Sp. z o.o.

Gdansk, Poland

Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie

Warsaw, Poland

National Scientific Center of Neurosurgery N.N. Burdenko

Moscow, Russia

St. Mary's Hospital Incheon

Incheon, South Korea

Hospital Clinic de Barcelona

Barcelona, Spain

University Hospital Virgen Arrixaca

El Palmar, Spain

Centro Especial Ramon y Cajal

Madrid, Spain

Hospital General De Asturias

Oviedo, Spain

Southmead Hospital Bristol

Bristol, United Kingdom

Queen Elizabeth University Hospital

Glasgow, United Kingdom

Charing Cross Hospital

London, United Kingdom

Royal Victoria Infirmary

Newcastle upon Tyne, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02686125

Related Trials

Deep Brain Stimulation Surgery for Movement Disorders

NCT015815801 location

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

NCT0366460919 locations

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT065536254 locations

Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

NCT065542881 location

Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia

NCT073251751 location